|
Biocentury: Regeneron using Interleukin Antibody Receptors for Asthma …
OneMedPlace (blog) An estimated 25 million Americans suffer from Asthma, but current medications such as inhalers have been deemed ineffective for 10-20% of its users. Regneron (REGN) and Sanofi (SAN) have partnered to crease a new Asthma drug, Dupilumab. In their … Clearing The Air On The Sanofi-Regeneron Asthma Drug Trial |
View full post on asthma – Google News